京都大学 · 医学
Yukinori Matsuo教授の研究室は、がん治療における呼吸動揺対策（RMM）の最適化と、特に肝細胞癌に対する立体定向的体外放射線治療（SBRT）の安全性・有効性の検証を柱としています。また、膵がん治療における化学放射線療法の有効性や、放射線腫瘍学医のメンタルヘルス（バーンアウト）に関する疫学的調査にも取り組んでいます。臨床的実務と科学的根拠の両面から、がん治療の質の向上を目指した包括的研究が展開されています。
Figures are computed from collected data and may differ slightly.
Respiratory motion management (RMM) systems in external and stereotactic radiotherapies have been developed in the past two decades. Japanese medical service fee regulations introduced reimbursement for RMM from April 2012. Based on thorough discussions among the four academic societies concerned, these Guidelines have been developed to enable staff (radiation oncologists, radiological technologists, medical physicists, radiotherapy quality managers, radiation oncology nurses, and others) to app
Stereotactic body radiotherapy (SBRT), a type of external beam radiotherapy, yields local control of hepatocellular carcinoma (HCC) at rates as high as 90%. SBRT has been recognized as an alternative therapy for patients for whom standard modalities such as surgery (resection or transplantation) or ablation are deemed unsuitable. SBRT has the potential to improve the prognosis of HCC, as it can be used as an adjunct to other treatment modalities. The assessment of post-SBRT images of the treated
Treatment with gemcitabine combined with radiation therapy according to the present schedule is well tolerated and can provide prolonged survival in patients with localized, unresectable pancreatic cancer.
This study aimed to evaluate the self-reported prevalence of burnout and psychological morbidity among radiation oncologists members of the Kyoto Radiation Oncology Study Group (KROSG) and to identify factors contributing to burnout. We mailed an anonymous survey to 125 radiation oncologists members of the KROSG. The survey included; the demographic data, the Maslach Burnout Inventory - Human Services Survey (MBI-HSS) and the 12-item General Health Questionnaire (GHQ-12). There were 87 responses
Open papers in the app to read, cite, and organize with AI.
